Data / Form D filings / PROTEOGENIX INC
PROTEOGENIX INC: Form D filings
PROTEOGENIX INC, a biotechnology company in Costa Mesa, CA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on April 14, 2010, reports $4 million sold of a $4.4 million offering to 5 investors.
Find out what PROTEOGENIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3545 HOWARD WAY, Costa Mesa, CA, 92626
- Phone
- (714) 445-0100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1179366
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2010 | New notice | $4,400,000 | $4,000,000 | $400,000 | 5 | Apr 5, 2010 | sec.gov |
| Aug 13, 2009 | New notice | $4,002,500 | $4,002,500 | $0 | 5 | Aug 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald Mooney | Executive Officer, Director | |
| Mike E. Allen | Executive Officer | |
| Steven G. Burrill | Director | |
| Michael G. Gravett | Executive Officer | |
| Richard G. Creager | Director | |
| Srinivasa Nagalla | Director | |
| Fred G. Cohen | Director | |
| Thomas E. Grove | Executive Officer | |
| David G. Levison | Director | |
| Vijay G. Lathi | Director | |
| Durlin E. Hickok | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Apr 12, 2010 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROTEOGENIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.